15-06-2022
Ocean 14 Capital invests in AION
Ocean 14 Capital Ltd., a private equity firm that invests in companies and technologies offering sustainable solutions for...
29-04-2022
Aker BioMarine - first quarter 2022
29 April 2022: Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 56.9 million and Adjusted...
17-02-2022
Aker BioMarine - results for the fourth quarter and full year 2021
Aker BioMarine ASA (“Aker BioMarine” or “the company”) reports revenues of USD 75.7 million and Adjusted EBITDA of USD 7.2...
17-01-2022
Aker BioMarine appoints new EVP for Human Health & Nutrition business area
Simon Seward has been appointed EVP of Human Health & Nutrition in Aker BioMarine ASA from today. He is an industry leader...
17-01-2022
New Study: Krill Oil Significantly Reduces Major Cardiovascular Risk Factors
A ‘game-changer’ within heart health, says researcher. Krill oil significantly reduces triglyceride levels in the blood - an...
02-09-2021
Aker BioMarine appoints SVP Investor Relations
Aker BioMarine ASA is pleased to announce that Carl Christian Bachke has been appointed SVP Investor Relations effective...
26-05-2021
Aker BioMarine appoints Douglas C. Hicks as SVP, Business Development & Strategy
Aker BioMarine, the global biotech innovator and world-leading supplier of krill, announces the appointment of biotechnology...
14-04-2021
Aker BioMarine lists on Oslo Børs
Euronext today congratulates Aker BioMarine on its transfer from Euronext Growth to Oslo Børs (ticker code: AKBM).
09-03-2021
Aker BioMarine commits to industry-leading emissions-free operations in Antarctica
Aker BioMarine launches its ambitious sustainability goals towards 2030.